| ||
| Phase II hyperfractionated accelerated radiation therapy (HART ... Phase II hyperfractionated accelerated radiation therapy (HART) for unresectable non-small cell lung cancer (NSCLC): preliminary results of ECOG 4593 ... www.asco.org/ascov2/Meetings/Abstracts?&vmview... | ||
| Agennix Announces Publication of Data From Talactoferrin Phase II ... ... Non-Small Cell Lung Cancer Published in Journal of Thoracic Oncology ... The maximum duration of treatment with talactoferrin or placebo was 18 weeks, ... www.live-pr.com/.../agennix-announces-publication-of-data-r... | ||
| Treatment of inoperable advanced non-small-cell lung cancer ... The Canadian Agency for Drugs and Technologies in Health is a national body that provides Canada's federal, provincial, and territorial health care decision ... cadth.ca/en/products/health-technology-assessment/.../360 |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment